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1. Introduction
   Leishmaniasis is a protozoa disease which has been 
observed in many parts of the world. World Health 
Organizeation (WHO) reported near 12 million infected 
patients, while there is a risk of infection by leishmania 
parasites for 350 million other people. The annual incidence 
of new cases is about 2 million out of which 1.2 million have 
cutaneous leshmaniasis (CL)[1].
   CL, is one of the three clearly distinguishable clinical 
manifestations of leishmaniasis which leads to a chronic, 
non-contagious infection with skin ulcer that heals 
spontaneously in most cases, leaving an unsightly scar[2].
   Due to intracellular location of the parasite it is difficult 
to treat leishmaniasis. Current leishmaniasis treatment 
protocols are based on antimony compounds which have 
unwanted side effects and sometimes are inefficient. The 
effects of available topical leishmanicidal products are 
minimal. Therefore, it is necessary to find and develop 
new therapeutic components with high efficacy and safety 
in order to replace or supplement those currently used 
drugs[3,4].
   Medicinal plants are potential sources of natural products 
which could be considered as alternatives to conventional 
drugs[5]. Traditional medicine is a popular therapeautic 
method in areas where leishmaniasis is endemic[4,6]. 
Euphorbiaceae family is one of the largest families of the 
phylum Anthophyta. In this family, the genus Euphorbia is 
the largest, which comprises over 2 000 species, grows in the 
forms of laticiferous, shrubs, herbs and small trees, living 
in different parts of the world such as the temperate and 
tropical zones of Asia and other[7].
   Euphorbia species have been successfully used for the 
treatment of CL by local people in Mashhad suburb, Iran, 
where growing number of cases are reported recently[8,9].
   The goal of this study was to find the scientific evidence 
for the leishmanicidal effect of methanolic Soxhlet extract 
ARTICLE INFO                           ABSTRACT
Objective: To evaluate leishmanicidal effects of Euphorbia erythadenia plant extract.
Methods: Extraction was done using methanolic Soxhlet of dried and ground aerial parts of the 
plant. Then, five different extract concentrations, in addition of positive, negative and solvent 
controls were prepared and added to a 24-well plate containing 40 000 parasites/well. The extract 
concentrations were 1, 0.5, 0.25, 0.125 and 0.062 5 mg/mL. Amphotricin B (0.5 mg/mL) was used as 
positive control while negative control contained only culture medium. After 3 d incubation at 25 °C 
the amount of parasites in each well was determined on each day of experiment microscopially 
using Neubar chamber.
Results: Soxhlet extract as well as amphotricin B killed all parasites at concentration of 1 mg/mL. 
The leshmanicidal activity of lower doses of extract was dose-dependent. The EC50 for Soxhlet 
extracts in dimethylsulfoxide was 0.30 mg/mL. The EC50 for Soxhlet extracts in methanol was 0.23 
mg/mL. No obvious effects from the control solvent on the Leishmania major promastigotes were 
observed.
Conclusions: The Soxhlet extract of Euphorbia erythadenia showed suitable leishmanicidal 
activity, especially in higher concentration fractions.
Article history:
Received 23 Dec 2013
Received in revised form 13 May 2014
Accepted 28 Jun 2014 
Available online 22 Jul 2014
Keywords:
Euphorbia erythadenia
Leishmanicidal activity
Leishmania major
Promastigotes
Reza Kazemi Oskuee et al./Asian Pac J Trop Biomed 2014; 4(Suppl 2): S581-S583S582
of Euphorbia erythadenia (E. erythadenia) on promastigotes 
of Leishmania major (L. major) in vitro.
2. Materials and methods
2.1. Plant material
   E. erythadenia was collected from near Kerman (Kerman 
Province, Iran). The aerial part of the plant was dried in 
shade and powdered. 
   The plant material was identified in the Herbarium of 
Ferdowsi University of Mashhad (Mashhad, Iran) and voucher 
sample was preserved for reference at the Herbarium of 
Mashhad School of Pharmacy (Mashhad, Iran) with reference 
number 301.
2.2. Preparation of extract 
   The plant powder (50 g) was extracted with 200 mL 
methanol for 24 h using Soxhlet apparatus. Then the extract 
was dried and solvent was removed by rotary evaporator and 
kept in refrigerator until use. 
2.3. Leishmania parasites
   Promastigotes of L. major strain MRHO/IR/75/ER, were 
obtained by isolation of the amastigotes from the lesions 
of infected BALB/c mice followed by transformation into 
promastigotes on Novy-MacNeal-Nicolle medium. Then 
the promastigotes were subcultured in RPMI 1640 (Sigma) 
supplemented with 10% fetal calf serum, 2 mmol/L glutamine, 
100 IU/mL of penicillin and 100 mg/mL of stereptomycin 
sulfate (RPMI-FCS) at 25 °C. To perform leishmanicidal assays, 
stationary-phase promastigotes were used.
2.4. Assay of leishmanicidal activity
   The assay was performed according to the previously 
reported method[10]. Breifly, L. major promastigotes were 
seeded at 40 000 parasites/well in 24-well plate in 400 µL 
RPMI-FCS. The extract were dissolved in dimethylsulfoxide 
(DMSO) and added further 400 µL/well to give final 
concentrations of 1 mg/mL. Then serial two-fold dilutions 
were prepared. After treatment, promastigotes were 
incubated over a period of 3 d at 25 °C and the amount of 
the parasites in each well was determined on days 1, 2 and 
3 of experiment using Neubar chamber under a microscope. 
Positive and negative controls including amphotricin 
B (0.5 mg/mL) and culture media were used, respectively. 
DMSO and methanol alone were also used as solvent control.
2.5. Statistical analysis
   Statistical analysis was carried out using One-way ANOVA 
and multiple comparison Tukey-Kramer test was used to 
compare the mean of different treatment groups. The EC50 
was determined by Litchfoeld and Wilcoxon method.
3. Results
   To give an exploratory motivation to ethnomedicinal 
utilization of E. erythadenia, in this study the leishmanicidal 
effect of methanolic Soxhlet extract of E. erythadenia was 
assessed on promastigotes of L. major in vitro.
   Soxhlet extract of the aerial part of E. erythadenia were 
prepared and tried against promastigotes of L. major.
    Both DMSO and methanol diluted extracts of E. erythadenia 
showed leishmaniacidal activity. Parasites were killed by 
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Figure 1. Effect of different concentrations of E. erythadenia Soxhlet extract in DMSO against L. major promastigotes.
A: 24 h, B: 48 h and C: 72 h after incubation. a: Control; b: DMSO; c: Amphotricin B; d: Extract (1 mg/mL); e: Extract (0.5 mg/mL); f: Extract (0.25 mg/mL); g: 
Extract (0.125 mg/mL); h: Extract (0.062 5 mg/mL). Each bar represents the mean依SEM of the number of promastigotes in 12 wells. ***: P<0.001, **: P<0.01, *: 
P<0.05 Tukey-Kramer test.
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Figure 2. Effect of different concentration of E. erythadenia Soxhlet extract in methanol against L. major promastigotes.
A: 24 h, B: 48 h and C: 72 h after incubation. a: Control; b: Methanol; c: Amphotricin B; d: Extract (1 mg/mL); e: Extract (0.5 mg/mL); f: Extract (0.25 mg/mL); g: 
Extract (0.125 mg/mL); h: Extract (0.062 5 mg/mL). Each bar represents the mean依SEM of the number of promastigotes in 12 wells. ***: P<0.001, **: P<0.01, *: 
P<0.05 Tukey-Kramer test.
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different concentrations of Soxhlet methanolic extract of E. 
erythadenia in DMSO, in a dose-dependent manner (Figure 
1). The EC50 for soxhlet methanolic extract of E. erythadenia 
in DMSO was 0.3 mg/mL after 1 d of incubation. DMSO did not 
have any effect on the L. major promastigotes.
   Also, different concentrations of Soxhlet methanolic 
extract of E. erythadenia in methanol killed parasites dose-
dependently (Figure 2). The EC50 for Soxhlet methanolic 
extract of E. erythadenia in methanol was 0.23 mg/mL after 1 d 
of incubation. Methanol did not showed signifigant effect on 
the L. major promastigotes.
   All tested concentration of extract exhibited leishmanicidal 
activity after 1, 2 and 3 d of incubation. Although the number 
of live promastigotes after 3 d of incubation was lower than 
those of 1 and 2 d of incubation, no significant differences 
between these groups was observed.
4. Discussion
   Individuals in developing countries generally utilize 
the plant(s)-derived preparations and consider them to 
be effective against CL without any experimental base to 
demonstrate the activity of such plants. In the absence of an 
effective vaccine and difficulties of chemicals, (for example, 
invasive administration), people are using medicinal plants 
sold on the nearby market as a solution for cure their 
wounds. Topical use of the E. erythadenia latex is one of 
those cures for the treatment of CL.
   The present study was done on promastigotes to assess its 
claimed efficacy using an in vitro assay based toxicity.
   The leishmanicidal activity of the E. erythadenia could 
be attributed to different constituent of extract. Jaafari et 
al. in their study on Euphorbia myrsinites, reported that 
the methanolic extract at a concentration of 1 mg/mL had 
suitable leishmanicidal activity which killed the L. major 
promastigotes in a dose-dependent manner, with an EC50 
value between 0.25 mg/mL[7,8]. A study on Euphorbia 
lagascae extract compounds, reported moderate anti-
leishmanial activity of stilbenes against promastigotes[11]. 
Also taxane type diterpenoids, which are structurally 
similar to myrisinane type diterpenoids, present in the 
Euphorbia genera had shown anti-leishmanial activity[12]. 
In another study, triterpene derived from two Euphorbia 
species were evaluated for their antileishmanial and 
antitrypanosomal activity on Leishmania infantum 
and Trypanosoma cruzi  and showed 76% and 64% 
antiparasitic for the test compounds, respectively[13]. 
The chloroform fraction of Euphorbia aellenii (1 mg/mL) 
in DMSO, also showed a growth inhibitory effect on L. 
major promastigotes, with an IC50 value of (140依24) µg/mL 
compared with amphotericin B [(0.29 依0.05) µg/mL] and 
pentamidine [(5.09依0.04) µg/mL][6].
   In a study on the herbal formulation composed of 
Euphorbia mysinites, Alkanna tinctoria and Peganum 
harmala, it has been reported that herbal combination 
in comparison with glucantime is more effective on 
experimental leishmaniasis induced in BALB/c mice; hence 
it could be considered as an alternative of glucantime in 
the treatment of leishmaniasis[14].
   The results of our study showed that Soxhlet extract 
of E.erythadenia have suitable leishmanicidal activity, 
especially in higher concentration fractions. Further 
fractionation of the E. erythadenia is required to pinpoint 
leishmanicidal constituent(s).
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